Neuropathy and Related Findings in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To describe the development and progression of neuropathy and related findings among patients with type 1 diabetes who participated in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. RESEARCH DESIGN AND METHODS: The main diabetic peripheral neuropathy (DPN) outcome was assessed using clinical symptoms, signs, and nerve conduction study results during DCCT and repeated in EDIC year 13/14. Cardiovascular autonomic neuropathy (CAN) was assessed by R-R response to paced breathing, Valsalva ratio, and blood pressure response to standing during DCCT and in EDIC years 13/14 and 16/17. Additionally, symptoms reflecting neuropathic pain and autonomic function (including hypoglycemia awareness) were collected yearly in EDIC using standardized questionnaires; peripheral neuropathy was also assessed annually using the Michigan Neuropathy Screening Instrument. Assessments of genitourinary function were collected at EDIC year 10. RESULTS: Intensive therapy during the DCCT significantly reduced the risk of DPN and CAN at DCCT closeout (64% and 45%, respectively, P < 0.01). The prevalence and incidence of DPN and CAN remained significantly lower in the DCCT intensive therapy group compared with the DCCT conventional therapy group through EDIC year 13/14. CONCLUSIONS: The persistent effects of prior intensive therapy on neuropathy measures through 14 years of EDIC largely mirror those observed for other diabetes complications. DCCT/EDIC provides important information on the influence of glycemic control, and the clinical course of diabetic neuropathy, and, most important, on how to prevent neuropathy in type 1 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A combination of typical symptomatology and symmetrical distal sensory loss, or typical signs in the absence of symptoms, in a person with DM is highly suggestive of DPN and may not require additional evaluations or referral.547,565–567”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [565]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The diagnosis of DPN is principally a clinical one.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [565]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The Diabetes Control and Complications Trial (DCCT) and its observational follow-up study, Epidemiology of Diabetes Interventions and Complications (EDIC), conclusively demonstrated that intensive glucose control applied early in the course of type 1 diabetes (T1D), significantly reduces the risk of developing CAN [2–4].”
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Electrophysiological testing or referral to a neurologist is rarely needed for diagnosis, except in situations where the clinical features are atypical, the diagnosis is unclear, and a different etiology is suspected.547,554,565”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [565]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Tesfaye, S., Boulton, A. J. M., Dyck, P. J., Freeman, R., Horowitz, M., Kempler, P., Lauria, G., Malik, R. A., Spallone, V., Vinik, A., et al. (2010) · Diabetes Care · doi:10.2337/dc10-1303 · Cited by 2,690
The global burden of diabetic foot disease
Boulton, A. J., Vileikyte, L., Ragnarson-Tennvall, G., & Apelqvist, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67698-2 · Cited by 2,566 · cited 1×
“Painful symptoms are frequently refractory to treatment, and loss of protective sensation heightens the risk for foot ulceration and lowerextremity amputations (19,20).”
BackgroundVascular risk factors and diabetic neuropathy
Tesfaye, S., Chaturvedi, N., Eaton, S. E. M., Ward, J. D., Manes, C., Ionescu-Tirgoviste, C., Witte, D. R., & Fuller, J. H. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa032782 · Cited by 1,323
Feldman, E. L., Stevens, M. J., Thomas, P. K., Brown, M. B., Canal, N., & Greene, D. A. (1994) · Diabetes Care · doi:10.2337/diacare.17.11.1281 · Cited by 1,293
Spallone, V., Ziegler, D., Freeman, R., Bernardi, L., Frontoni, S., Pop‐Busui, R., Stevens, M., Kempler, P., Hilsted, J., Tesfaye, S., et al. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1239 · Cited by 957
Self-citationEffect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.287.19.2563 · Cited by 941
Maser, R. E., Mitchell, B. D., Vinik, A. I., & Freeman, R. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1895 · Cited by 578 · cited 1×
“Yet, CAN is an independent predictor of mortality (21,22), possibly by promoting life-threatening arrhythmias and sudden death in response to a variety of insults including drug side effects, hypoglycemia, hypokalemia, hypotension, or ischemia (23).”
Background
Cited by
Items 401–500 of 572
Kim, C., Pop‐Busui, R., Braffett, B. H., Cleary, P. A., Bebu, I., Wessells, H., Orchard, T. J., & Sarma, A. V. (2015) · The Journal of Sexual Medicine · doi:10.1111/jsm.13029 · Cited by 1
Self-citationBlackman, S. M., & Kelly, A. T. (2016) · Journal of Cystic Fibrosis · doi:10.1016/s1569-1993(16)00019-9 · Cited by 1
Diabetespatienten mit chronischer Niereninsuffizienz: Neue Aspekte in Diagnostik und Therapie
Pommer, W., & Oser, B. (2015) · Der Nephrologe · doi:10.1007/s11560-014-0974-x · Cited by 1
Powell, R. O. (2014) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Do You Have Any Long-Term Health Conditions?
Rayner, H. C., Thomas, M., & Milford, D. V. (2015) · Springer eBooks · doi:10.1007/978-3-319-23458-8_5 · Cited by 1
Neuropathies chez les diabétiques
Lozeron, P. (2016) · Encyclopédie médico-chirurgicale. Neurologie · doi:10.1016/s0246-0378(16)75572-2 · Cited by 1
Lozeron, P. (2017) · EMC - Neurologia · doi:10.1016/s1634-7072(16)81776-6 · Cited by 1
Ziegler, D., & Mesa-Pérez, J. A. (2018) · Alad · doi:10.24875/alad.18000313 · Cited by 1
Clinical and Pharmacological basis for the Use of Telmisartan in Patients with Diabetic Neuropathy
Sh, A. A., Alexandre, K., Nikoloz, G., & Chirakadze, K. (2018) · Diabetes & its Complications · doi:10.33425/2639-9326.1037 · Cited by 1
Krishna Prasad, G., V (2019) · International Journal of Contemporary Medical Research [IJCMR] · doi:10.21276/ijcmr.2019.6.10.6 · Cited by 1
Screening For Peripheral Sensory Neuropathy In a Tunisian Population of Patients With Diabetes
Jemai, C., Frigui, S., & Mami, F. B. (2020) · European Journal of Medical and Health Sciences · doi:10.24018/ejmed.2020.2.4.382 · Cited by 1
Grabarczyk, T. R., Roberts, A. W., Mahnken, J. D., & Grauer, D. W. (2021) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2021.08.010 · Cited by 1
Underlying Mechanisms and Advances in Management of Chronic Pain in Diabetes Mellitus
Kilcoyne, J., & Starkweather, A. R. (2020) · Topics in Pain Management · doi:10.1097/01.tpm.0000717700.03590.b6 · Cited by 1
New Trends: Time in Range and the Use of Continuous Glucose Monitoring Devices on Glycemic Control
Souza, K. L. V. D., Rassi, M. M. B., de Sá, D. A. R., Bussuan, R. M., Rodrigues, L. C. D. S., & Arbex, A. K. (2021) · European Journal of Medical and Health Sciences · doi:10.24018/ejmed.2021.3.1.491 · Cited by 1
Neuropatia autonomiczna układu sercowo-naczyniowego w przebiegu cukrzycy - aktualny stan wiedzy.
Kieć‐Wilk, B., Gastoł, J., & Pawliński, Ł. (2019) · Postępy Biochemii · doi:10.18388/pb.2019_287 · Cited by 1
UPDATE OF CARDIOVASCULAR AUTONOMIC NEUROPATHY IN PATIENTS WITH DIABETES
Universitatea de Medicină și Farmacie „Carol Davila“, B., Nica, A. E., Dobjansch, C., Universitatea de Medicină și Farmacie „Carol Davila“, B., Parlițeanu, O. A., Universitatea de Medicină și Farmacie „Carol Davila“, B., Rusu, E., Universitatea de Medicină și Farmacie „Carol Davila“, B., Radulian, G., & Universitatea de Medicină și Farmacie „Carol Davila“, B. (2021) · Romanian Medical Journal · doi:10.37897/rmj.2021.2.6 · Cited by 1
Differential diagnosis of polyneuropathies in diabetes mellitus
Khramilin, V. N. (2021) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2021-12-256-265 · Cited by 1
Vas, P. R. J., & Mahdi‐Rogers, M. (2019) · Springer eBooks · doi:10.1007/978-3-319-17918-6_3 · Cited by 1
Diabetes and the Nervous System
Vinik, A. I., CASELLINI, C. M., & Neumann, S. A. (2018) · Endocrinology · doi:10.1007/978-3-319-44433-8_10 · Cited by 1
ISMAIL, A. F., Nasir, S. M., Ismail, T. S. T., Ahmad, W. A. N. W., Rahman, W. F. W. A., Sirajudeen, K. N. S., & Din, T. A. D. A. T. (2021) · Malaysian Applied Biology · doi:10.55230/mabjournal.v50i2.2148 · Cited by 1
Neuropathy in Type 1 and Type 2 Diabetes
Akıncı, G., Nowacek, D. G., & Callaghan, B. C. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-15613-7_4 · Cited by 1
Hamdaoui, M. S., Midoun, N., & Belhadj, M. (2023) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2023.08.005 · Cited by 1
Azmi, S., Alam, U., & Malik, R. A. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch45 · Cited by 1
Fan, X., Cao, J., Yan, G., Zhao, Y., Wang, Y., Wang, X., & Mi, J. (2024) · PLoS ONE · doi:10.1371/journal.pone.0310732 · Cited by 1
“Nevertheless, the management of blood glucose levels has limited impact on individuals diagnosed with type 2 DPN [7].”
Lewicka, M., Korzeniewska-Dyl, I., Moczulski, D. K., Woźniak-Kosek, A., Zawadzka, M., & Henrykowska, G. A. (2025) · Acta Biochimica Polonica · doi:10.3389/abp.2025.14569 · Cited by 1
Kallionpää, H. (2014) · UTUPub (University of Turku) · Cited by 1
Khunkaew, S. (2019) · Research Online (University of Wollongong) · Cited by 1
Koech, J. (2018) · Cited by 1
Toyoshima, M. T. K. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2021.tde-11012022-135720 · Cited by 1
The Distribution of Type 1 Diabetes Onset in the United States by Demographic Factors
Beckstrand, M. (2015) · ScholarWorks (Walden University) · Cited by 1
Lithovius, R. (2015) · Työväentutkimus Vuosikirja
Sundberg, F. (2014) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Neuropathie induite par la thérapie chez les patients diabétiques : ne pas traiter trop vite !
Djellas, Y. B., Meillet, L., Schillo, F., Penfornis, A., Vergès, B. L., & Borot, S. (2015) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(15)30244-3
Auf das metabolische Gedächtnis ist Verlass
Stirban, O. A. (2016) · Info Diabetologie · doi:10.1007/s15034-016-0832-1
Kostitska, I. O. (2016) · ScienceRise Medical Science · doi:10.15587/2519-4798.2016.76567
Diabetesscreening und Risikocheck über die Autofluoreszenz der Haut
Stirban, O. A. (2016) · Info Diabetologie · doi:10.1007/s15034-016-0995-9
Diabetes, neuropathy, and old age
Dineen, J. M., & Gibbons, C. H. (2017) · Wiley eBooks · doi:10.1002/9781118954621.ch11
Neuropathies diabétiques périphériques : compléter notre trousse à outils
Rigalleau, V., Monlun, M., Blanco, L., Hadjadj, S., Archambeaud, F., & Mohammedi, K. (2017) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(17)30032-9
Complications in cystic fibrosis-related diabetes
Choudhury, M. (2017) · ORCA Online Research @Cardiff (Cardiff University)
Kasz, R. (2017) · UTS ePRESS (University of Technology Sydney)
Lytvyn, Y. (2016) · TSpace (University of Toronto)
Взаємозв’язок між діабетичним гастропарезом і ризиком розвитку гіпоглікемічних станів
Kostitska, I. O., & Mankovsky, B. (2017) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.13.3.2017.104110
Painful diabetic neuropathy and its treatment by pregabaline
Khaustova, O. O. (2017) · Clinical endocrinology and endocrine surgery · doi:10.24026/1818-1384.2(58).2017.105628
Laser Doppler Imager Flare (LDIflare) small fibre function
Vas, P. R. J. (2026) · Warwick Research Archive Portal (University of Warwick) · doi:10.82444/warw.33751948
Krentowska, A., & Adamska, A. (2015) · Clinical Diabetology · doi:10.5603/dk.2015.0023
Bezerra, D. P. D. S. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2018.tde-02082018-111817
Behandlung und Prävention von Diabetes: Erfolge und Herausforderungen
Bitzer, B., & Müller‐Wieland, D. (2018) · Public Health Forum · doi:10.1515/pubhef-2018-0052
Fall 2: Zielwerte – 30 Jahre, ♀, DM Typ 1
Wetekam, B. (2018) · Springer eBooks · doi:10.1007/978-3-662-55972-7_2
Role of endothelin-1 in the renal handling of salt in early Type 1 diabetes mellitus
Culshaw, G. (2018) · ERA
Kardiovaskuläre Folgen der diabetischen Neuropathie
Ziegler, D. (2018) · Kardiologie up2date · doi:10.1055/a-0660-6606
Altaf, Q. (2018) · University of Birmingham Institutional Research Archive (University of Birmingham)
Devarajooh, C. (2018) · University of Malaya Students Repository
COP Analysis in Type 2 Diabetics with Peripheral Diabetic Neuropathy
Cano, D. C. T., Zequera, M. L., & Castro, G. (2019) · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · doi:10.1007/978-3-030-30636-6_55
Conte, C., & Secchi, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814833-4.00023-x
Sztanek, F., Molnár, Á., Banyai, D., Sándor, P., Lőrincz, H., Szentpéteri, A., Seres, I., Balogh, Z., & Paragh, G. (2018) · Diabetologia Hungarica · doi:10.24121/dh.2018.4
The effect of Alpha lipoic acid on glycemic control in patients with diabetic polyneuropathy
Okuroğlu, N., Sertbaş, M., Eryılmaz, M., Manukyan, N. Y., Şahinsev, A., Sertbaş, Y., & Özdemir, A. (2019) · Abant Medical Journal · doi:10.5505/abantmedj.2019.68235
Xu, M. (2019) · TSpace (University of Toronto)
SOKOLOVA, L. K., Belchina, Y. B., Ozeryanskaya, O. E., Cherviakova, S. A., & Tronko, M. D. (2019) · Endokrynologia · doi:10.31793/1680-1466.2019.24-3.223
Kwang-Chun, O., & Kang, R.-H. (2019) · Muller Journal of Medical Sciences and Research · doi:10.4103/mjmsr.mjmsr_8_19
Тактика и стратегия лечения диабетической невропатии
Литвиненко, И. В., Николаевич, Я. С., Голохвастов, С. Ю., Naumov, K. M., Булатов, А. Р., & Ушакова, Н. О. (2020) · Нервные болезни · doi:10.24411/2226-0757-2020-12148
Boulton, A. J. M., & Malik, R. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00053-6
Rayner, H. C., Thomas, M. E., & Milford, D. V. (2020) · Springer eBooks · doi:10.1007/978-3-030-43027-6_6
Kosivtsova, O. V., Platov, M. P., & Kochetov, S. A. (2020) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2020-3-111-116
Les hypoglycémies et leurs conséquences dans l’essai DCCT
Moutairou, A. (2019) · theses.fr (ABES) · doi:10.70675/2381bb1ez244ez4e52z8a7dz46479a89bf4a
Neuropathic Pain Syndrome: Diabetic and Other Neuropathies
Sawada, A., & Yamakage, M. (2020) · Springer eBooks · doi:10.1007/978-981-15-2933-7_14
Stirban, O. A. (2020) · Diabetes aktuell · doi:10.1055/a-1215-5199
Novel approaches to pancreas allograft surveillance
Barnes, J. (2019) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-go8r6v9oo
Management of patients with neurological complications of diabetes mellitus
Kosivtsova, O. V., Chuprina, E. N., Strokov, I. A., Platov, M. P., & Kochetov, S. A. (2020) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2020-19-114-119
Kamel, J. T. (2020) · Minerva Access (University of Melbourne)
Macrovascular and microvascular disease in diabetic foot disease
Lowry, D. (2019) · University of Birmingham Institutional Research Archive (University of Birmingham)
Weiss, J. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-72084-7.00011-5
Sztanek, F., Demeter, Z. O., Katkó, M., Molnár, Á., Jakab, A. Á., & Harangi, M. (2021) · Diabetologia Hungarica · doi:10.24121/dh.2021.4
Wojeck, B. S., & Inzucchi, S. E. (2021) · Diabetes Spectrum · doi:10.2337/ds20-0070
Diabetic Central Neuropathy: A Cause of Central Sleep Apnea
Malone, J. I. (2021) · Medical Research Archives · doi:10.18103/mra.v9i12.2608
Cardiovascular Pathology – a Factor of the Adverse Course of Diabetic Polyneuropathy
CHUPRYNA, G., Dubynetska, V. M., & Kachur, K. (2021) · Family Medicine · doi:10.30841/2307-5112.2-3.2021.240761
“The incidence of DP is higher in people with type 2 DM (6,100 per 100,000 people per year) than in people with type 1 DM (2,800 per 100,000 people per year) [2, 11, 14, 15].”
BackgroundDiabetes and the Nervous System
Vinik, A. I., CASELLINI, C. M., & Neumann, S. A. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_10-3
Diabetes and the Nervous System
Vinik, A. I., CASELLINI, C. M., & Neumann, S. A. (2018) · Endocrinology · doi:10.1007/978-3-319-27316-7_10-2
Assessment of neuronal dysfunction in patient groups with high risk of neuropathy
Magony, S. (2022) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.11209
Diabetischer Fuß: Fokus auf die Neuropathie
Stirban, O. A. (2022) · Info Diabetologie · doi:10.1007/s15034-022-3866-6
Plummer, E. S. (2022) · American Diabetes Association eBooks · doi:10.2337/9781580407700.ch06
A neuropathia diabetica genetikai aspektusai
Putz, Z., Tordai, D. Z., Hajdú, N., Vági, O. E., Kempler, M., Békeffy, M. Z., Körei, A. E., Istenes, I., & Kempler, P. (2022) · Diabetologia Hungarica · doi:10.24121/dh.2022.4
A dohányzás szerepe a cukorbetegség és szövődményeinek kialakulásában
Körei, A. E., Putz, Z., Istenes, I., Tordai, D. Z., Hajdú, N., Békeffy, M. Z., Vági, O. E., & Kempler, P. (2022) · Diabetologia Hungarica · doi:10.24121/dh.2022.18
Molecular Basis of Neurodegeneration and Therapies in Diabetic Neuropathy
Bist, R. (2021) · Current Research in Diabetes & Obesity Journal · doi:10.19080/crdoj.2021.15.555909
“It is most frequent and long-persisting disease as well as bilateral presentation that occurred in 3/4 of the patient those have neurological disorder along with DM [26,27].”
BackgroundCroosu, S. S. (2022) · VBN Forskningsportal (Aalborg Universitet) · doi:10.54337/aau485088931
Gluba-Brzózka, A., Rysz-Górzyńska, M., & Rysz, J. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-26681-2_9
Diabetic Neuropathy Misdiagnosed as Right Lower Limb Injury
Vasu, A. (2023) · Springer eBooks · doi:10.1007/978-3-031-28296-6_18
Analysis of medications for symptomatic treatment of the painful diabetic polyneuropathy in Ukraine
Власенко, І. О., Mankovsky, B., & Monashnenko, O. O. (2023) · Fìtoterapìâ · doi:10.32782/2522-9680-2023-1-71
Navarro, X., & Kennedy, W. R. (2023) · Springer eBooks · doi:10.1007/978-3-031-20999-4_59
Secondary Complications: Pancreas Versus Islet Transplantation
Maffi, P., Catarinella, D., & Secchi, A. (2023) · Springer eBooks · doi:10.1007/978-3-031-20999-4_64
Aziz, N. A., Al-Hashimi, B. A.-R., & Mohammed, A. J. (2023) · International Journal of Advanced Community Medicine · doi:10.33545/comed.2023.v6.i4a.273
Journal of Population and Therapeutics and Clinical Pharmacology
Tahir, T., Rehman, F. U., Ilyas, A., Mehtab, M., Naseem, A., Asif, M., Shahzad, K., Idrees, K., & Lodhi, K. (2023) · doi:10.53555//jptcp.v30i17.3643
Tahir, T., Rehman, F. U., Ilyas, A., Mehtab, D. M., Naseem, D. A., Asif, M., Shahzad, K., Idrees, D. K., & Lodhi, K. (2023) · doi:10.53555/jptcp.v30i17.3643
“Second, non–diabetic dysglycemia is linked to the suggestively higher danger of unfavorable results in HF-REF [6].”
BackgroundRahmanian, M., Yaghoobpoor, S., Deravi, N., Poudineh, M., Mirmohammadali, S. N., Kashanizadeh, M. G., Poopak, A., Faridzadeh, A., Erabi, G., Amouei, E., et al. (2024) · Neurology Asia · doi:10.54029/2024utt
“While good glycemic control has been demonstrated to delay the onset of diabetic peripheral neuropathy in type 1 diabetes 14 , this impact has been less well evidenced in T2DM.”
BackgroundA diabeteses neuropathia jelentősége és diagnosztikája a klinikai gyakorlatban
Sztanek, F., Hernyák, M., & Kempler, P. (2024) · Lege Artis Medicinae · doi:10.33616/lam.34.0111
Lozeron, P. (2024) · EMC - Neurologia · doi:10.1016/s1634-7072(24)48980-0
Kanthed, P., Barasker, S. K., & Ravikumar, C. M. (2024) · Indian Journal of Pain · doi:10.4103/ijpn.ijpn_119_23
Metadata
- Authors
- Martin, C. L., Albers, J. W., Pop-Busui, R., & for the DCCT/EDIC Research Group
- Affiliations
- University of Michigan (US)
- Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan Medical School, Ann Arbor, MI
- Corresponding author
- Martin, Catherine L.
- ORCID
- Martin, Catherine L.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2013-12-11
- Volume
- 37
- Issue
- 1
- Pages
- 31-38
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3868000
- OpenAlex
- W2115038969
- Cited by
- 499
- References
- 30
- Citations by year
- 2026: 25 · 2025: 27 · 2024: 45 · 2023: 38 · 2022: 40 · 2021: 57 · 2020: 50 · 2019: 41 · 2018: 45 · 2017: 28 · 2016: 34 · 2015: 42 · 2014: 23 · 2013: 4
- FWCI
- 27.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Eli Lilly and Company
- Sanofi
- BD
- Roche Diabetes Care
- National Institutes of Health (UL1TR000041, UL1TR000114, 5u01dk094157-13, UL1TR001449)
- Abbott Diabetes Care
- National Eye Institute
- National Institute of Diabetes and Digestive and Kidney Diseases (U01DK094176, U01-DK094157, P30DK020572)
- National Institute of Neurological Disorders and Stroke
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- diabetic peripheral neuropathy, cardiac autonomic neuropathy, type 1 diabetes, tight glycemic control, neuropathy progression, neuropathic pain, hypoglycemia awareness, genitourinary function, Michigan Neuropathy Screening Instrument, DCCT/EDIC, neuropathy prevention
- MeSH terms
- Adolescent, Adult, Aged, Blood Glucose, Blood Pressure, Diabetes Mellitus, Type 1, Diabetic Neuropathies, Dose-Response Relationship, Drug, Female, Glycated Hemoglobin, Humans, Insulin, Male, Middle Aged, Neural Conduction, Peripheral Nervous System Diseases, Risk Factors, Incidence, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.